I
Ian F. Dunn
Researcher at University of Oklahoma
Publications - 333
Citations - 18300
Ian F. Dunn is an academic researcher from University of Oklahoma. The author has contributed to research in topics: Medicine & Meningioma. The author has an hindex of 54, co-authored 289 publications receiving 14343 citations. Previous affiliations of Ian F. Dunn include Boston Children's Hospital & Glasgow Royal Infirmary.
Papers
More filters
Journal ArticleDOI
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie,Pablo Tamayo,Jesse S. Boehm,So Young Kim,Susan Moody,Ian F. Dunn,Anna C. Schinzel,Peter Sandy,Etienne Meylan,Claudia Scholl,Stefan Fröhling,Edmond M. Chan,Martin L. Sos,Kathrin Michel,Craig H. Mermel,Serena J. Silver,Barbara A. Weir,Jan H. Reiling,Qing Sheng,Piyush Gupta,Raymond C. Wadlow,Raymond C. Wadlow,Hanh Le,Sebastian Hoersch,Ben S. Wittner,Ben S. Wittner,Sridhar Ramaswamy,Sridhar Ramaswamy,David M. Livingston,David M. Sabatini,Matthew Meyerson,Matthew Meyerson,Roman K. Thomas,Eric S. Lander,Jill P. Mesirov,David E. Root,D. Gary Gilliland,Tyler Jacks,William C. Hahn +38 more
TL;DR: Observations indicate that TBK1 and NF-κB signalling are essential in KRAS mutant tumours, and establish a general approach for the rational identification of co-dependent pathways in cancer.
Journal ArticleDOI
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
Priscilla K. Brastianos,Scott L. Carter,Scott L. Carter,Sandro Santagata,Sandro Santagata,Daniel P. Cahill,Amaro Taylor-Weiner,Robert T. Jones,Eliezer M. Van Allen,Eliezer M. Van Allen,Michael S. Lawrence,Peleg M. Horowitz,Kristian Cibulskis,Keith L. Ligon,Keith L. Ligon,Josep Tabernero,Joan Seoane,Elena Martínez-Sáez,William T. Curry,Ian F. Dunn,Sun Ha Paek,Sung Hye Park,Aaron McKenna,Aaron Chevalier,Mara Rosenberg,Fred G. Barker,Corey M. Gill,Paul Van Hummelen,Aaron R. Thorner,Bruce E. Johnson,Mai P. Hoang,Toni K. Choueiri,Sabina Signoretti,Carrie Sougnez,Michael S. Rabin,Nan Lin,Eric P. Winer,Anat Stemmer-Rachamimov,Matthew Meyerson,Levi A. Garraway,Levi A. Garraway,Stacey Gabriel,Eric S. Lander,Rameen Beroukhim,Rameen Beroukhim,Tracy T. Batchelor,José Baselga,David N. Louis,Gad Getz,Gad Getz,William C. Hahn,William C. Hahn +51 more
TL;DR: Stricker et al. as discussed by the authors performed whole-exome sequencing of 86 matched brain metastases, primary tumors, and normal tissue and found potentially clinically informative alterations in the brain metastasis not detected in the matched primary-tumor sample.
Journal ArticleDOI
Artificial intelligence in cancer imaging: Clinical challenges and applications.
Wenya Linda Bi,Ahmed Hosny,Matthew B. Schabath,Maryellen L. Giger,Nicolai Juul Birkbak,Nicolai Juul Birkbak,Alireza Mehrtash,Alireza Mehrtash,Tavis Allison,Tavis Allison,Omar Arnaout,Christopher Abbosh,Christopher Abbosh,Ian F. Dunn,Raymond H. Mak,Rulla M. Tamimi,Clare M. Tempany,Charles Swanton,Charles Swanton,Udo Hoffmann,Lawrence H. Schwartz,Lawrence H. Schwartz,Robert J. Gillies,Raymond Y. Huang,Hugo J.W.L. Aerts,Hugo J.W.L. Aerts +25 more
TL;DR: The authors review the current state of AI as applied to medical imaging of cancer and describe advances in 4 tumor types to illustrate how common clinical problems are being addressed.
Journal ArticleDOI
CDK8 is a colorectal cancer oncogene that regulates β-catenin activity
Ron Firestein,Adam J. Bass,So Young Kim,Ian F. Dunn,Serena J. Silver,Isil Guney,Isil Guney,Ellen Freed,Azra H. Ligon,Natalie Vena,Shuji Ogino,Milan G. Chheda,Milan G. Chheda,Pablo Tamayo,Stephen P. Finn,Yashaswi Shrestha,Yashaswi Shrestha,Jesse S. Boehm,Supriya Rani Jain,Emeric Bojarski,Craig H. Mermel,Craig H. Mermel,Jordi Barretina,Jordi Barretina,Jennifer Ang Chan,José Baselga,Josep Tabernero,David E. Root,Charles S. Fuchs,Massimo Loda,Ramesh A. Shivdasani,Matthew Meyerson,William C. Hahn +32 more
TL;DR: It is shown that the suppression of CDK8 expression inhibits proliferation in colon cancer cells characterized by high levels ofCDK8 and β-catenin hyperactivity, suggesting that therapeutic interventions targeting CDK 8 may confer a clinical benefit in β-Catenin-driven malignancies.
Journal ArticleDOI
Integrative genomic approaches identify IKBKE as a breast cancer oncogene.
Jesse S. Boehm,Jean J. Zhao,Jun Yao,So Young Kim,Ron Firestein,Ian F. Dunn,Sarah K. Sjostrom,Levi A. Garraway,Stanislawa Weremowicz,Andrea L. Richardson,Heidi Greulich,Heidi Greulich,Heidi Greulich,Carly J. Stewart,Laura Mulvey,Rhine R. Shen,Lauren Ambrogio,Lauren Ambrogio,Tomoko Hirozane-Kishikawa,David E. Hill,Marc Vidal,Matthew Meyerson,Matthew Meyerson,Matthew Meyerson,Jennifer K. Grenier,Greg Hinkle,Greg Hinkle,David E. Root,Thomas M. Roberts,Eric S. Lander,Kornelia Polyak,William C. Hahn +31 more
TL;DR: It is shown that activation of the ERK and phosphatidylinositol 3-kinase (PI3K) signaling pathways cooperate to transform human cells and suggest a mechanism for NF-kappaB activation in breast cancer, implicate the NF- kappaB pathway as a downstream mediator of PI3K, and provide a framework for integrated genomic approaches in oncogene discovery.